EDQM: New Guideline for sterile Substances published for Comment
Recommendation
28/29 April 2026
From QbD to Process Validation
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The draft of the new guideline "Content of the dossier for sterile substances" (PA/PH/CEP (23) 54, draft 4) is now available for comments on the EDQM (European Directorate for the Quality of Medicines & HealthCare) website. Remarks and comments can be submitted until 15 August 2024.
The guideline consists of three chapters, with chapter 3 containing further subsections. The document is organised as follows:
1. Introduction
2. Scope
3. Documentation to be provided for the sterile substance
- Justification for method of sterilisation Manufacturing areas
- Summary of manufacturing process related to sterile filtration/aseptic processing
- Information on filters used
- Validation of the filters used
- Sterilisation of filters and processing equipment
- Pre-filtration Bioburden
- Re-use of filters
- Aseptic processing
- Process Simulation / Validation
- Sterilisation of Packaging
- Re-test Period
On the EDQM website go to the section "Consultation space" to find and comment on the draft of the Guideline "Content of the dossier for sterile substances" (PA/PH/CEP (23) 54, draft 4).
Related GMP News
18.03.2026ICH M4Q(R2): List of comments published
11.03.2026ASMF: CMDh updates Information on "Worksharing Procedure"
04.03.2026CMDh: Update of Q&As for Generic Drug Submissions
18.02.2026HMA/CMDh: Update to the Best Practice Guides on Variations
11.02.2026Q&As for Centralized Procedures - further Update
04.02.2026EMA: IRIS Document revised